ResearcherSir Run Run Shaw HospitalActive in the last 2 years
Songmei Lou
Matched on ORCID iD 0000-0002-7187-9142; OpenAlex author ID A5007423521. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 6
- LRP1 regulates GDNF secretion and perineural invasion in pancreatic cancer via PI3K/AKT signaling. Co-author DOI 10.1016/j.cellsig.2025.112225↗
- Single-cell RNA sequencing uncovers an immunosuppressive program in PDAC mast cells: tumour-driven activation, proliferation, and association with Treg recruit… Co-author DOI 10.1080/07853890.2026.2724762↗
- FNA-based lipidomics reveals coordinated lipid metabolic remodeling in pancreatic cancer. Last author DOI 10.3389/fmolb.2026.1823383↗
- Regulation and Crosstalk of Cells and Factors in the Pancreatic Cancer Microenvironment. First author DOI 10.2174/0115680096317840240723071018↗
- Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. Co-author DOI 10.1093/abbs/gmz071↗
- Endoscopic Ultrasound-guided Celiac Plexus Neurolysis to Alleviate Intractable Pain Caused by Advanced Pancreatic Cancer. Co-author DOI 10.1097/sle.0000000000000683↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shenhao Liu · 2 shared papers, 2026 · strength 0.63
- Jian Xu · 2 shared papers, 2026 · strength 0.62
- Paper Single-cell RNA sequencing uncovers an immunosuppressive program in PDAC mast cells: tumour-driven activation, prolifer… DOI 10.1080/07853890.2026.2724762↗
- Paper LRP1 regulates GDNF secretion and perineural invasion in pancreatic cancer via PI3K/AKT signaling. DOI 10.1016/j.cellsig.2025.112225↗
- Feng Luo · 1 shared paper, 2025 · strength 0.33
- Jia Xu · 1 shared paper, 2025 · strength 0.33
- Mengli Wu · 1 shared paper, 2026 · strength 0.32
- Mengying Zhu · 1 shared paper, 2026 · strength 0.30
- Jian Xu · 1 shared paper, 2019 · strength 0.10
- Feng Luo · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.